Patient professional reference
Professional Reference articles are written by UK doctors and are based on research evidence, UK and European Guidelines. They are designed for health professionals to use. You may find one of our health articles more useful.
Synonyms: giant platelet syndrome
This is a congenital bleeding disorder characterised by thrombocytopenia and large platelets.
The molecular defect involves the absence of a platelet membrane glycoprotein (platelet membrane von Willebrand factor) leading to defective platelet adhesion. This has been found to be caused by mutation in the GP1BA gene, the GP1BB gene, or the GP9 gene. It is familial with autosomal recessive inheritance.
- Symptoms are of variable abnormal bleeding, including easy bruising, nosebleeds, mucosal bleeding, menorrhagia and, occasionally, gastrointestinal bleeding.
- Pregnancy in patients with Bernard Soulier syndrome is characterised by antenatal haemorrhage, intrapartum haemorrhage and postpartum haemorrhage, which may be delayed and severe.[5, 6]
- The severity of symptoms is very variable.
- Heterozygotes usually have no bleeding abnormality.
- May-Hegglin anomaly; autosomal dominant disorder of variable thrombocytopenia associated with purpura and bleeding, giant platelets and large inclusion bodies in the white cells
- Thrombocytopenia-absent radius syndrome.
- Von Willebrand's disease.
- Idiopathic thrombocytopenic purpura (ITP).
- Other inherited giant platelet disorders, eg grey platelet syndrome.
- FBC and film: platelet count is usually low but may be normal. Giant platelets are seen on the blood film.
- Bleeding time is prolonged and may be longer than 20 minutes.
- Platelet aggregation studies: platelets do not aggregate in response to ristocetin or von Willebrand factor.
- Flow cytometry can demonstrate abnormalities of platelet membrane glycoprotein.
- For patients with moderate-to-severe symptoms, some restriction of activity, eg contact sports, may be necessary.
- The patient should be aware of the increased bleeding tendency when considering surgery.
- Avoid antiplatelet medication, eg aspirin.
In general, no medications are needed. Treatment of bleeding episodes includes:
- Antifibrinolytic agents, eg epsilon-aminocaproic acid, may be used for mucosal bleeding.
- For surgery or life-threatening haemorrhage, platelet transfusion is the only available therapy for surgery or life-threatening bleeding.
- Desmopressin acetate (DDAVP®) has been shown to shorten the bleeding time in some patients with Bernard-Soulier syndrome. It does not work for all patients.
- Recombinant activated factor VII has also been used.
- The patient may develop antiplatelet antibodies due to the presence of glycoproteins Ib/IX/V which are present on the transfused platelets but absent from the patient's own platelets.
- Therefore platelet transfusions should be reserved for surgery or potentially life-threatening bleeding.
The tendency to bleed easily lasts for life but may decrease as the patient gets older.
Further reading and references
Pham A, Wang J; Bernard-Soulier syndrome: an inherited platelet disorder. Arch Pathol Lab Med. 2007 Dec131(12):1834-6.
Geil JD; Bernard-Soulier Syndrome, eMedicine, Jun 2009
Toogeh G, Keyhani M, Sharifian R, et al; A study of Bernard-Soulier syndrome in Tehran, Iran. Arch Iran Med. 2010 Nov13(6):549-51.
Prabu P, Parapia LA; Bernard-Soulier syndrome in pregnancy. Clin Lab Haematol. 2006 Jun28(3):198-201.
Peitsidis P, Datta T, Pafilis I, et al; Bernard Soulier syndrome in pregnancy: a systematic review. Haemophilia. 2010 Jul 116(4):584-91. Epub 2010 Jan 12.
Linden MD, Frelinger AL 3rd, Barnard MR, et al; Application of flow cytometry to platelet disorders. Semin Thromb Hemost. 2004 Oct30(5):501-11.
Kostopanagiotou G, Siafaka I, Sikiotis C, et al; Anesthetic and perioperative management of a patient with Bernard-Soulier syndrome. J Clin Anesth. 2004 Sep16(6):458-60.
Lanza F; Bernard-Soulier syndrome (hemorrhagiparous thrombocytic dystrophy). Orphanet J Rare Dis. 2006 Nov 161:46.
Lopez JA et al; Bernard-Soulier syndrome. Blood. 1998 Jun 1591(12):4397-418.
Hello,I have been diagnosed with essential thrombocytosis in June 2013 and have started taking hydroxyurea in July 2014. Until now, on average I have been taking 2 capsules per day (500mg each), one...Magnolia11
Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. Patient Platform Limited has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.